SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
SEC Accession No. 0001140361-23-029172
Filing Date
2023-06-09
Accepted
2023-06-09 17:23:57
Documents
8
Period of Report
2023-06-09

Document Format Files

Seq Description Document Type Size
1 PREM14A ny20009217x1_prem14a.htm PREM14A 1965823
2 FILING FEES TABLE ny20009217x1_ex107.htm EX-FILING FEES 19896
3 logo_cyclerion-c.jpg GRAPHIC 43166
4 logo_stifel.jpg GRAPHIC 30645
5 ny20009217x1_pc01.jpg GRAPHIC 809817
6 ny20009217x1_pc02.jpg GRAPHIC 677899
7 ny20009217x1_pc03.jpg GRAPHIC 57137
8 sig_stifelnicolaus2.jpg GRAPHIC 38729
  Complete submission text file 0001140361-23-029172.txt   4267990
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Filer) CIK: 0001755237 (see all company filings)

IRS No.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: PREM14A | Act: 34 | File No.: 001-38787 | Film No.: 231006395
SIC: 2834 Pharmaceutical Preparations